Search / Trial NCT06223178

Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve

Launched by XIAOMEI SHAO · Jan 16, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Diminished Ovarian Reserve Acupoint Thumb Tack Needle Randomized Controlled Trial

Description

There will be a multi-center, randomized, sham-controlled trial. 106 patients will be randomly assigned into thumb-tack needle acupuncture or sham-acupuncture in 1:1 ratio. All the patents will achieve 12 sessions of verum or sham treatments in 20 weeks(12 weeks for treatment and 8 weeks for follow-up). Patients, outcome assessors and statisticians are masked from group assignment. The study is aim to evaluate the efficacy of thumb-tack needle for DOR.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * 18 years old ≤ age \< 40 years old, female;
  • * Clinical diagnosis of Diminished Ovarian Reserve: meet both items in twice tests with an interval of at least 4 weeks(tested between 2rd to 4th day of menstrual cycle):
  • 1. 10 IU/L \< FSH \< 20 IU/L,
  • 2. Anti-Müllerian hormone(AMH) \< 1.1ng/mL.
  • * without any mind disease, willing to participate in the study and sign the informed consent.
  • * without any other treatment.
  • Exclusion Criteria:
  • * Low or no response to exogenous gonadotropins, or with congenital anomalies in the development of the reproductive tract;
  • * Pregnant or breastfeeding;
  • * Abnormal body temperatures at the moment;
  • * Psychopath, alcoholic, Patient with severe depression, history of substance abuse and severe primary diseases of cardiovascular, liver, kidney and hematopoietic system;
  • * Currently enrolled in other clinical trials or refuse to cooperate with the study protocol.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Hangzhou, Zhejiang, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0